Immediate Impact

57 standout
Sub-graph 1 of 23

Citing Papers

Efficacy of Tezepelumab in Severe, Uncontrolled Asthma: Pooled Analysis of the PATHWAY and NAVIGATOR Clinical Trials
2023 Standout
Asthma
2023 Standout
4 intermediate papers

Works of L. P. Boulet being referenced

Omalizumab therapy: patients who achieve greatest benefit for their asthma experience greatest benefit for rhinitis
2008
Quality of life in asthma clinical trials: comparison of salmeterol and salbutamol.
1995

Author Peers

Author Last Decade Papers Cites
L. P. Boulet 128 182 8 54 8 243
Yasser Shehata 32 98 167 11 273
Eva Martínez Moragón 144 156 31 14 232
Ulrik Søes‐Petersen 138 200 27 14 287
António Bugalho‐Almeida 149 225 133 8 288
Andreea Steriu 60 122 51 7 182
J. M. Antó 70 93 49 6 287
Nils E. Billo 78 109 33 6 173
Asja Stipić-Marković 65 78 41 14 257
Karl Holden 126 127 13 8 180
Paul Y. Qaqundah 91 125 99 11 283

All Works

Loading papers...

Rankless by CCL
2026